Picture of ExpreS2ion Biotech Holding AB logo

EXPRS2 ExpreS2ion Biotech Holding AB Balance Sheet

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for ExpreS2ion Biotech Holding AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:ARSARSARSARSPRESS
Standards:
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Cash
Short Term Investments
Cash and Short Term Investments5.4210713911157.6
Net Total Accounts Receivable
Net Total Receivables4.355.17.1110.810.6
Prepaid Expenses
Total Current Assets10.111214613268.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment1.191.291.210.911.77
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets18.711915213774.3
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities12.218.27.4631.411.4
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities19.824.311.63413.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity-1.0894.514010360.9
Total Liabilities & Shareholders' Equity18.711915213774.3
Total Common Shares Outstanding